Ascend Laboratories
DRONABINOL
Manufacturer:
Ascend Laboratories
Name:
DRONABINOL
HCPCS Code Descriptor:
Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Category:
Q Code
HCPCS:
Q0167
NDC(s):
67877-0755-60, 67877-0754-60, 67877-0753-60, 67877-0570-60, 67877-0569-60, 67877-0568-60, 53097-0571-60, 53097-0570-60, 53097-0569-60, 53097-0568-60, 00904-7145-04, 00904-7144-61
Primary Type:
Oncology-Anti-Emetic
Generic Status:
Multi-Source
Route of Administration:
Oral
About:
DRONABINOL is an Oncology-Anti-Emetic drug manufactured by Ascend Laboratories and administered via the Oral route of administration. The Q Code: Q0167 is aligned to the drug DRONABINOL.